Critical Contrast: Transcat (TRNS) & Its Rivals

Transcat (NASDAQ: TRNS) is one of 24 public companies in the “Electronic Component” industry, but how does it contrast to its rivals? We will compare Transcat to related businesses based on the strength of its analyst recommendations, dividends, institutional ownership, risk, profitability, earnings and valuation.

Analyst Ratings

This is a summary of current ratings for Transcat and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Transcat 0 0 3 0 3.00
Transcat Competitors 40 260 518 12 2.60

Transcat currently has a consensus target price of $20.00, indicating a potential upside of 27.15%. As a group, “Electronic Component” companies have a potential upside of 0.78%. Given Transcat’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Transcat is more favorable than its rivals.

Profitability

This table compares Transcat and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Transcat 3.24% 10.03% 4.94%
Transcat Competitors -2.83% -0.23% 1.93%

Risk and Volatility

Transcat has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500. Comparatively, Transcat’s rivals have a beta of 1.01, indicating that their average stock price is 1% more volatile than the S&P 500.

Insider & Institutional Ownership

57.1% of Transcat shares are owned by institutional investors. Comparatively, 56.4% of shares of all “Electronic Component” companies are owned by institutional investors. 8.8% of Transcat shares are owned by insiders. Comparatively, 9.0% of shares of all “Electronic Component” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Transcat and its rivals top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Transcat $143.90 million $4.52 million 23.13
Transcat Competitors $1.21 billion $129.73 million 105.31

Transcat’s rivals have higher revenue and earnings than Transcat. Transcat is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Transcat beats its rivals on 7 of the 13 factors compared.

About Transcat

Transcat, Inc. is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak). Through its Distribution segment, the Company markets, sells and rents national brand instruments to customers around the globe. The Company is focused on providing its services and products to the life science industries, which include pharmaceutical, biotechnology, medical device manufacturing and other Food and Drug Administration (FDA)-regulated businesses.

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply